SCHEMBL1234705

SCHEMBL1234705

CCCCCc1cc(O)c2cc(-c3cccs3)oc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 8/20 0.53
CNR2 P34972 8/20 0.53
GPR55 Q9Y2T6 1/20 0.50
ALDH1A1 P00352 2/20 0.44
TP53 P04637 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTPRS Q13332 1/20 0.44
QPCT Q16769 1/20 0.42
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
PTGS2 P35354 2/20 0.37
CYP3A4 P08684 1/20 0.37
FAAH O00519 1/20 0.36
CES1 P23141 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1234583 0.75 ALDH1A1 (0.46) CNR1CNR2GPR55ALDH1A1TP53
SCHEMBL1236073 0.74 CNR2 (0.54) CNR1CNR2GPR55ALDH1A1TP53
SCHEMBL2271081 0.74 CNR1 (0.59) CNR1CNR2GPR55ALDH1A1TP53
SCHEMBL1236052 0.72 PTGS2 (0.50) CNR1CNR2GPR55ALDH1A1TP53
SCHEMBL1236537 0.68 CNR1 (0.51) CNR1CNR2GPR55ALDH1A1TP53
SCHEMBL18876269 0.68 KDM4E (0.58) ALDH1A1TP53GAATSHRHTT
SCHEMBL18876426 0.67 KDM4E (0.57) ALDH1A1TP53GAATSHRSMN1; SMN2
SCHEMBL2162023 0.67 ALDH1A1 (0.56) CNR1CNR2GPR55ALDH1A1TP53
SCHEMBL18044490 0.66 KDM4E (0.39) ALDH1A1TP53GAANPC1LMNA
SCHEMBL27911329 0.66 KDM4E (0.39) ALDH1A1TP53GAANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US claimed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US claimed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO claimed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE CNR1, CNR2, GPR18 CNR1 1/4885CNR2 2/4885GPR55 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.